OTRIVINE ADULT

0.1 %w/v Nasal Spray Solution

GlaxoSmithKline Consumer Healthcare (Ireland) LimitedPA0678/120/002

Main Information

Trade NameOTRIVINE ADULT
Active SubstancesXYLOMETAZOLINE HYDROCHLORIDE
Strength0.1 %w/v
Dosage FormNasal Spray Solution
Licence HolderGlaxoSmithKline Consumer Healthcare (Ireland) Limited
Licence NumberPA0678/120/002

Group Information

ATC CodeR01AA07 Sympathomimetics, plain

Status

Authorised/WithdrawnAuthorised
Licence Issued29/07/2016
Supply StatusSupply through pharmacies only
Dispensing StatusProduct not subject to medical prescription
Marketing StatusMarketed
Promotion StatusPromotion to the general public
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.